Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04157270 · ClinicalTrials.gov registry record
LOTUS: Global Acute Stroke Study Utilizing Penumbra System
A clinical trial, sponsored by Penumbra.
- Terminated
- Registry status
- 23
- Enrollment target
NCT04157270 is a clinical trial that was terminated before completion, run by Penumbra. The registered enrollment target is 23 participants.
The verdict
NCT04157270 was terminated before completion, sponsored by Penumbra.
- TERMINATED
- Registry status
- 23 participants
- Enrollment target
Study Summary
The primary objective of this study is to demonstrate safety and effectiveness of the Penumbra System in a population with acute ischemic stroke (AIS) secondary to intracranial large vessel occlusion (LVO).
Interventions
- DEVICE Penumbra System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2020-01-12 |
| Est. Completion | 2021-05-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04157270
The ClinicalTrials.gov registry entry for NCT04157270 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Penumbra, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Penumbra System is the first listed.
NCT04157270 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04157270 about?
NCT04157270 is a clinical study titled "LOTUS: Global Acute Stroke Study Utilizing Penumbra System". The primary objective of this study is to demonstrate safety and effectiveness of the Penumbra System in a population with acute ischemic stroke (AIS) secondary to intracranial large vessel occlusion (LVO).
What is the current status of trial NCT04157270?
This trial is currently terminated. The enrollment target is 23 participants. The study started on 2020-01-12. Estimated completion is 2021-05-10.
What interventions are being tested in trial NCT04157270?
The interventions under investigation include: Penumbra System (DEVICE).
Who is sponsoring clinical trial NCT04157270?
This trial is sponsored by Penumbra, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.